USD 0.4
(0.0%)
Breakdown | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | 87.98 Thousand |
Cost of Revenue | - | - | - | - | 2500.00 | 59.96 Thousand |
Gross Profit | - | - | - | - | -2500.00 | 28.02 Thousand |
Operating Expenses | 9660.00 | 45.66 Thousand | 17.12 Million | 1.35 Million | 84.6 Thousand | 172.11 Thousand |
Selling, General and Administrative Expenses | 9660.00 | 45.66 Thousand | 17.12 Million | 1.35 Million | 84.6 Thousand | 145.52 Thousand |
Research and Development Expenses | - | - | - | - | - | 26.58 Thousand |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 9660.00 | 45.66 Thousand | 17.12 Million | 1.35 Million | 87.1 Thousand | 232.07 Thousand |
Operating Income | -9660.00 | -45.66 Thousand | -17.12 Million | -1.35 Million | -87.1 Thousand | -144.09 Thousand |
Interest Expense | 16 Thousand | 26 Thousand | 35.96 Thousand | 33.81 Thousand | - | - |
Income Tax Expense | -167.89 Thousand | -228.48 Thousand | -17.12 Thousand | -1355.75 | - | -40.55 Thousand |
Earnings before Tax | 192.65 Thousand | -71.66 Thousand | -17.16 Million | -1.39 Million | -99.93 Thousand | -134.61 Thousand |
Net Income | 192.65 Thousand | -71.66 Thousand | -17.16 Million | -1.39 Million | -99.93 Thousand | -134.61 Thousand |
Earnings Per Share Basic | 0.00 | -0.00 | -0.15 | -0.01 | -0.24 | -0.33 |
Earnings Per Share Diluted | 0.00 | -0.00 | -0.15 | -0.01 | -0.24 | -0.33 |
Weighted Average Shares Outstanding | 337.12 Million | 147.22 Million | 118.05 Million | 118.05 Million | 410.94 Thousand | 408.75 Thousand |
Weighted Average Shares Outstanding (Diluted) | 337.12 Million | 147.22 Million | 118.05 Million | 118.05 Million | 410.94 Thousand | 408.75 Thousand |
Gross Margin | - | - | - | - | - | 0.32 |
EBIT Margin | - | - | - | - | - | -1.64 |
Profit Margin | - | - | - | - | - | -1.53 |
EBITDA | 208.66 Thousand | -45.66 Thousand | -35.96 Thousand | -36.04 Thousand | -83.16 Thousand | -144.09 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | -1.64 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 54.22 Thousand | 7580.00 | 9660.00 | 550.00 | 750.00 | 500.00 |
Selling, General and Administrative Expenses | 54.22 Thousand | 7580.00 | - | 550.00 | 750.00 | 500.00 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 7580.00 | - | - | - | - |
Cost and Expenses | 54.22 Thousand | 7580.00 | 9660.00 | 550.00 | 750.00 | 500.00 |
Operating Income | -54.23 Thousand | -7580.00 | -9660.00 | -550.00 | -750.00 | -500.00 |
Interest Expense | 2077.00 | 2077.00 | 16 Thousand | 2077.00 | 2077.00 | 5925.00 |
Income Tax Expense | - | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand | -122.08 Thousand |
Earnings before Tax | -56.3 Thousand | -9657.00 | 192.65 Thousand | -31.93 Thousand | -2827.00 | 241.2 Thousand |
Net Income | -56.3 Thousand | -9657.00 | 192.65 Thousand | -31.93 Thousand | -2827.00 | 241.2 Thousand |
Earnings Per Share Basic | -0.00 | - | - | -0.00 | - | 0.00 |
Earnings Per Share Diluted | -0.00 | - | - | -0.00 | - | 0.00 |
Weighted Average Shares Outstanding | 337.12 Million | 337.12 Million | 337.12 Million | 337.12 Million | 147.22 Million | 147.22 Million |
Weighted Average Shares Outstanding (Diluted) | 337.12 Million | 337.12 Million | 337.12 Million | 337.12 Million | 147.22 Million | 147.22 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -54.23 Thousand | -7580.00 | - | -550.00 | -750.00 | -500.00 |
Earnings Before Tax Margin | - | - | - | - | - | - |
XGC
NATHBIOGEN
SYTIXSE
DC-A
000995
WEGZY